Quality of care for secondary cardiovascular disease prevention in 2009-2017: population-wide cohort study of antiplatelet therapy use in Scotland.

Inna Thalmann,David Preiss,Iryna Schlackow,Alastair Gray,Borislava Mihaylova

BMJ quality & safety（2023）

引用 0|浏览4

暂无评分

摘要

APT use remains suboptimal for the secondary prevention of ASCVD, particularly among women and older patients, and following ischaemic stroke and PAD hospitalisations.

查看译文

关键词

chronic disease management, clinical practice guidelines, general practice, healthcare quality improvement, health policy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要